Seeking Alpha
  • The Scientist
    Awaiting CELG Abraxane data on panc CA. SPARC hypothesis controversial. Abrax does not improve OS in breast CA, which is usually SPARC+.
    Reply (2)
    • The Scientist: Perhaps destroying SPARC/stroma promotes metastasis - allows for easier malignant cell escape. Abrax should have worked better in breast CA.
    • Noreika: Off topic: Did ILNS.PK get halted today? I can't wait to see the Study 301 results!! (the non-carrier one) Or was it the Study 300?
      From other sites